Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Awards and Prizes | 4 | 2017 | 65 | 1.730 |
Why?
|
| Rheumatology | 4 | 2017 | 129 | 1.630 |
Why?
|
| Population Health | 3 | 2023 | 40 | 1.120 |
Why?
|
| Electronic Health Records | 3 | 2024 | 802 | 1.010 |
Why?
|
| Arthritis, Juvenile | 3 | 2024 | 42 | 0.880 |
Why?
|
| Data Accuracy | 1 | 2024 | 34 | 0.870 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2024 | 75 | 0.830 |
Why?
|
| Osteoarthropathy, Primary Hypertrophic | 1 | 2017 | 2 | 0.540 |
Why?
|
| Polyarteritis Nodosa | 1 | 2017 | 8 | 0.530 |
Why?
|
| Histiocytosis, Sinus | 1 | 2017 | 34 | 0.520 |
Why?
|
| Tuberculosis, Osteoarticular | 1 | 2016 | 4 | 0.500 |
Why?
|
| Tenosynovitis | 1 | 2016 | 7 | 0.500 |
Why?
|
| Hand Joints | 1 | 2016 | 6 | 0.500 |
Why?
|
| Spinal Cord Compression | 1 | 2016 | 33 | 0.490 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2016 | 45 | 0.480 |
Why?
|
| Vasculitis | 1 | 2016 | 50 | 0.480 |
Why?
|
| Societies, Medical | 3 | 2017 | 779 | 0.470 |
Why?
|
| Photography | 1 | 2014 | 86 | 0.410 |
Why?
|
| Gout | 1 | 2016 | 167 | 0.390 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2025 | 213 | 0.360 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 2681 | 0.360 |
Why?
|
| Genome-Wide Association Study | 4 | 2023 | 1830 | 0.300 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 308 | 0.220 |
Why?
|
| Air Pollution | 1 | 2025 | 74 | 0.220 |
Why?
|
| Fasciitis | 1 | 2024 | 19 | 0.210 |
Why?
|
| Women's Health | 1 | 2025 | 148 | 0.210 |
Why?
|
| Macrophage Activation Syndrome | 1 | 2023 | 11 | 0.210 |
Why?
|
| Social Determinants of Health | 1 | 2025 | 155 | 0.200 |
Why?
|
| Bone and Bones | 1 | 2025 | 301 | 0.200 |
Why?
|
| Radiography | 2 | 2017 | 819 | 0.200 |
Why?
|
| Rheumatic Diseases | 2 | 2014 | 73 | 0.200 |
Why?
|
| Eosinophilia | 1 | 2024 | 105 | 0.190 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2023 | 73 | 0.190 |
Why?
|
| Mycorrhizae | 1 | 2021 | 2 | 0.180 |
Why?
|
| Information Storage and Retrieval | 1 | 2022 | 64 | 0.180 |
Why?
|
| Basidiomycota | 1 | 2021 | 12 | 0.180 |
Why?
|
| Metabolomics | 1 | 2025 | 480 | 0.180 |
Why?
|
| Fixation, Ocular | 1 | 2021 | 18 | 0.170 |
Why?
|
| Coinfection | 1 | 2023 | 188 | 0.170 |
Why?
|
| Documentation | 1 | 2022 | 121 | 0.170 |
Why?
|
| Receptor, ErbB-4 | 1 | 2020 | 9 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2023 | 289 | 0.170 |
Why?
|
| Anemia, Sickle Cell | 1 | 2024 | 330 | 0.160 |
Why?
|
| Checklist | 1 | 2021 | 98 | 0.160 |
Why?
|
| Humans | 18 | 2025 | 132236 | 0.160 |
Why?
|
| Lung Diseases | 1 | 2023 | 408 | 0.160 |
Why?
|
| Health Resources | 1 | 2021 | 136 | 0.160 |
Why?
|
| United States | 3 | 2024 | 11688 | 0.150 |
Why?
|
| Adult | 7 | 2024 | 31622 | 0.150 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2020 | 75 | 0.150 |
Why?
|
| Middle Aged | 6 | 2025 | 29032 | 0.150 |
Why?
|
| Attitude | 1 | 2019 | 120 | 0.140 |
Why?
|
| Patients | 1 | 2019 | 129 | 0.140 |
Why?
|
| Talus | 1 | 2017 | 7 | 0.130 |
Why?
|
| Genetic Counseling | 1 | 2019 | 246 | 0.130 |
Why?
|
| Coronary Aneurysm | 1 | 2017 | 34 | 0.130 |
Why?
|
| Pericarditis | 1 | 2017 | 46 | 0.130 |
Why?
|
| Female | 10 | 2025 | 70778 | 0.130 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2016 | 25 | 0.130 |
Why?
|
| Trans-Activators | 1 | 2020 | 712 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2016 | 51 | 0.120 |
Why?
|
| Infliximab | 1 | 2016 | 69 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 893 | 0.120 |
Why?
|
| Aged | 4 | 2025 | 21471 | 0.120 |
Why?
|
| Cartilage, Articular | 1 | 2016 | 64 | 0.120 |
Why?
|
| Microscopy, Electron | 1 | 2016 | 339 | 0.120 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 430 | 0.120 |
Why?
|
| Lymph Nodes | 1 | 2017 | 389 | 0.110 |
Why?
|
| Mass Screening | 1 | 2021 | 831 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 3844 | 0.110 |
Why?
|
| Coronary Angiography | 1 | 2017 | 486 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2016 | 122 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2019 | 720 | 0.110 |
Why?
|
| Child | 7 | 2025 | 25783 | 0.110 |
Why?
|
| Intestine, Small | 1 | 2016 | 309 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2016 | 377 | 0.100 |
Why?
|
| History, 21st Century | 1 | 2014 | 271 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 1418 | 0.100 |
Why?
|
| Genetic Testing | 1 | 2019 | 1099 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2022 | 4003 | 0.090 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2023 | 2851 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 2165 | 0.070 |
Why?
|
| Male | 6 | 2025 | 65006 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2024 | 14735 | 0.070 |
Why?
|
| Ultrasonography | 1 | 2013 | 988 | 0.070 |
Why?
|
| Particulate Matter | 1 | 2025 | 79 | 0.060 |
Why?
|
| Postmenopause | 1 | 2025 | 153 | 0.060 |
Why?
|
| Tertiary Care Centers | 1 | 2025 | 259 | 0.050 |
Why?
|
| Phenotype | 2 | 2023 | 4538 | 0.050 |
Why?
|
| Air Pollutants | 1 | 2025 | 114 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2024 | 129 | 0.050 |
Why?
|
| Th17 Cells | 1 | 2024 | 98 | 0.050 |
Why?
|
| Proprotein Convertase 9 | 1 | 2023 | 81 | 0.050 |
Why?
|
| Bone Density | 1 | 2025 | 370 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 356 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 150 | 0.050 |
Why?
|
| Acclimatization | 1 | 2021 | 24 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 234 | 0.050 |
Why?
|
| Droughts | 1 | 2021 | 13 | 0.050 |
Why?
|
| Adolescent | 3 | 2025 | 20559 | 0.050 |
Why?
|
| Plant Roots | 1 | 2021 | 31 | 0.050 |
Why?
|
| Methotrexate | 1 | 2024 | 350 | 0.050 |
Why?
|
| Peru | 1 | 2021 | 56 | 0.040 |
Why?
|
| Symbiosis | 1 | 2021 | 103 | 0.040 |
Why?
|
| Fever | 1 | 2023 | 310 | 0.040 |
Why?
|
| Oligomenorrhea | 1 | 2020 | 2 | 0.040 |
Why?
|
| Ovarian Cysts | 1 | 2020 | 23 | 0.040 |
Why?
|
| Hyperandrogenism | 1 | 2020 | 25 | 0.040 |
Why?
|
| Superoxide Dismutase | 1 | 2020 | 176 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 675 | 0.040 |
Why?
|
| Infertility, Female | 1 | 2020 | 149 | 0.040 |
Why?
|
| Smoking | 1 | 2023 | 940 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2024 | 1962 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2023 | 1049 | 0.030 |
Why?
|
| Disease Progression | 1 | 2023 | 2230 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3093 | 0.030 |
Why?
|
| Texas | 1 | 2025 | 3632 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2020 | 623 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1556 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3414 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2023 | 6572 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2023 | 3356 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2020 | 2490 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 9966 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13048 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2025 | 17394 | 0.020 |
Why?
|